Clinical Perspectives - Biologics in IBD: What's All the Fuss?
Up until the present time, agents with relatively nonspecific anti-inflammatory or immunomodulatory effects such as 5-acetylsalicylic acid, corticosteroids and azathioprine have been the mainstay of inflammatory bowel disease medical therapy. These drugs have been quite useful in one or more clinica...
Saved in:
Main Author: | Hillary Steinhart |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2001-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2001/605398 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IBD 2009: Emerging Research Frontiers on the Path to a Cure
by: A Hillary Steinhart, et al.
Published: (2010-01-01) -
Success Run Waiting Times and Fuss-Catalan Numbers
by: S. J. Dilworth, et al.
Published: (2015-01-01) -
Applications of Fuss-Catalan Numbers to Success Runs of Bernoulli Trials
by: S. J. Dilworth, et al.
Published: (2016-01-01) -
IBD: Progress in Pathogenesis
by: Claudio Fiocchi, et al.
Published: (1993-01-01) -
The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
by: Jessica Mwinyi, et al.
Published: (2012-01-01)